Tropical Splenomegaly-Marsden et al. MEDICALJOURNAL falciparum in the peripheral blood of these patients is noteworthy in view of the frequency with which this parasite is encountered in blood-film surveys in Uganda.
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Brit. med. J., 1965, 1,-92-97 Withdrawal from a prolonged state of alcohol intoxication is characterized by a variety of symptoms, some of which merely produce discomfort to varying degrees, while others constitute a potential hazard to life (Johnson, 1961) . The principal sources of discomfort are sleeplessness, agitation, tremor, sweating, anorexia, nausea, and vomiting. A variable proportion of patients in the withdrawal state, approximately 10% of those seen in the clinic of this Foundation, develop more dangerous complications, including grand-mal seizures and delirium tremens.
The objectives of treatment for the withdrawal state are principally the amelioration of discomfort arising from the causes mentioned and the prevention of the more serious hazards. In recent years a succession of treatments have been employed, the classical sedatives being replaced to a considerable extent by insulin therapy, and still later by tranquillizers. The replacement of an old treatment by a new one should logically occur only if the new treatment can be shown clearly and objectively to offer advantages over the old. There has been very little objective evaluation of any of the methods employed in the treatment of the alcohol-withdrawal syndrome. The most recent addition to the drug therapy for this condition has been chlordiazepoxide (Librium). To the best of our knowledge there has been no adequately controlled comparison between the efficacy of chlordiazepoxide and that of the various tranquillizers previously in vogue. The present study was therefore devised with two principal purposes: (1) to evaluate the effectiveness of chlordiazepoxide in the treatment of the withdrawal syndrome, in comparison with a typical phenothiazine tranquillizer (promazine: Sparine) and with placebo treatment; and (2) to evolve objectively quantifiable methods which would be applicable to the evaluation of other new drugs that might be proposed for the treatment of alcohol-withdrawal symptoms.
Methods
Patients.-The subjects taking part in this study were 58 male alcoholic patients aged 28 to 59 years, all of whom entered the clinic voluntarily. The majority had been drinking up to the time of admission to the clinic; however, 17 of them had stopped drinking 10 hours or more before first being seen. The preceding period of heavy drinking had varied from five days up to several months. A few of the patients had palpably enlarged livers, but none had definite clinical evidence of cirrhosis. No patients were included in the study who showed definite evidence of any organic lesions other than those directly attributable to alcoholism.
Treatments.-The patients were assigned by rotation, according to the order of admission, to five treatment groups. The five treatments consisted of capsules containing, respectively, chlordiazepoxide 25 mg., chlordiazepoxide 50 mg., promazine 50 mg., promazine 100 mg., and placebo. All capsules were identical in size and appearance. The treatment schedule consisted of two capsules at 8 a.m., at noon, at 4 p.m., and at 10 p.m., so that the total daily dosage was chlordiazepoxide 200 or 400 mg., promazine 400 or 800 mg., or placebo.
The capsules were assigned code letters, their identities remaining unknown to the clinical staff until after completion of the study.
Measurements
Sleep.-The percentage of time slept was evaluated by the method described by Lasagna (1954) . The patient was observed every half-hour, day and night, to see whether he was awake or asleep. According to the finding at each check, the patient's record was credited with a half-hour of either sleep or wakefulness. The total time slept was expressed as a percentage of the total time of the period of observation. For reasons extraneous to the design of the study, the observations recorded between midnight and 7 a.m. were thought to be of questionable reliability and were therefore excluded. The values presented below refer to the observation period from 7 a.m. to midnight each day.
Blood-pressure and Pulse Rate.-Both blood-pressure and pulse rate were measured with the patient sitting in a chair. Blood-pressure was measured by means of a mercury sphygmomanometer, and the pulse rate by direct palpation.
Tremor.-Hand-tremor frequency was measured by means of a photoelectric tremometer specially devised for this study (Llewellyn-Thomas, 1962 Blood-pressure and Pulse Rate Fig. 1 illustrates the change in group mean values for systolic blood-pressure and pulse rate during the whole course of the experiment. The maximum differentiation between the various treatment groups was observed at the second observation period after the start of treatment. A statistical analysis was made of the results at this time, and at the sixth observation (Table II) . It can be seen from these results that all four drug treatments 9 January 1965 Alcohol-withdrawal Syndrome-Sereny and Kalant lowered the systolic blood-pressure in comparison with the placebo group. However, chlordiazepoxide produced this hypotensive effect gradually and progressively, while the effect of promazine was abrupt and immediate. At the second observation during the period of treatment it can be seen that promazine caused a significantly greater fall in blood-pressure than either dose of chlordiazepoxide or the placebo. There was no appreciable difference between the effects produced by the high and low doses of promazine, or between the high and low (loses of chlordiazepoxide. By the sixth observation all four drug treatments caused a significantly lower blood-pressure than the placebo, but did not differ from each other.
A further comparison between the various treatments was math in terms of the frequency of occurrence of potentially dangetrous hypotensive reactions. Such reactions were defined as those episodes in which the systolic blood-pressure fell to an arbi lrarily selected level of 100 mm. of mercury or less. As shown in Table III poxide 100 mg. also produced significantly more reactions than did the placebo.
At the second observation after the start of treatment both doses of promazine were found to raise the pulse rate significantly in comparison with the placebo. Both doses of chlordiazepoxide also raised the pulse rate in comparison with the placebo group, but the difference was not statistically significant (Table IV) . (Table V) . Because of large variations within groups, there were no significant differences between the treatment groups with respect to intention tremor until the sixth observation. At this point the mean frequency for the group on the high dose of chlordiazepoxide was significantly higher than that for the group on the high dose of promazine (P<0.05). There were no other significant differences between groups.
Skin Resistance
The change in log skin resistance from the admission value to the second observation during the treatment period is shown in The most important of the beneficial effects produced by all four drug treatments was an increase in the percentage of time slept. On the first day the large dose of promazine produced the greatest benefit. However, as can be seen in Fig. 4 A, Alcohol-withdrawal Syndrome-Sereny and Kalant
In this respect there is again a clear diminution of effectiveness of promazine from the first to the second and from the second to the third days of the study. On the first day promazine appeared to be approximately 50% more effective than chlordiazepoxide; on the second day they were virtually of equal potency; while on the third day promazine was less than half as potent as chlordiazepoxide, which continued to show essentially the same activity throughout the study (Fig. 4 B) .
The progressive development of tolerance to some of the effects of phenothiazines has been noted by other investigators. Kornetsky et al. (1959) ited by any of the treatments, and the reason for this lack of effect is not clear. In contrast, spontaneous tremor was significantly ameliorated by both doses of promazine, and this beneficial effect was sustained throughout the period of observation (Fig. 4 C) . Chlordiazepoxide was relatively ineffective with respect to spontaneous tremor at the beginning of the study, but the high dose appeared actually to increase both spontaneous and intention tremor throughout the period of treatment, so that at the last observation the frequency of both types of tremor was significantly higher in the chlordiazepoxide 100-mg. group than in the other active treatment groups. This finding is in keeping with the reported production of ataxia by large doses of chlordiazepoxide (Randall et al., 1960 ; Ticktin and Schultz, 1960; Roy et al., 1963 ; Koutsky and Sletten, 1963) .
Among the undesirable and potentially dangerous effects of all four treatments the most consistent and frequent were the production of hypotension and associated tachycardia. It may be that hypotension, by producing a feeling of weakness and giddiness, contributes in part to the sedative effect, since the patients are not anxious to get out of bed. However, this is a dangerous manner of achieving the goal, because of the risk of coronary or cerebral vascular thromboses occurring during hypotensive incidents, especially in older patients with vascular lesions (Witton, 1961) . Promazine appeared to be much more potent than chlordiazepoxide in this respect, since both doses produced an almost immediate and virtually equal effect. This indicates that both doses employed were already past the rising phase of the dose-response curve and were on the plateau of maximal effect. In contrast, the fall in mean blood-pressure was much more gradual with chlordiazepoxide, and the frequency of occurrence of hypotensive episodes was lower. However, there were still significantly more such reactions in the chlordiazepoxide group than in the placebo group. Chlordiazepoxide has been reported to increase food intake and weight gain in experimental animals (Randall et al., 1960) , and to increase the appetite in human patients (Baroody et al., 1962 ; Chesrow et al., 1962; Roy et al., 1963) . The present observations do not bear this out. Calorie intake tended to be higher, though not significantly so, in the placebo group than in the drug groups. It is not clear whether this is suggestive of a slight anorexiant effect or is merely a reflection of the fact that those in the drug groups slept more.
Because of the small numbers of patients suffering grand-mal seizures or delirium tremens no statistical comparison was made between groups with respect to the frequency of these complications. It is noteworthy, however, that while there were no such cases in the two chlordiazepoxide groups one case occurred in the placebo group and five cases in the two groups receiving promazine. These observations are in harmony with the reported anticonvulsant effect of chlordiazepoxide (Randall et al., 1960) Chessick and McFarland (1963 (1963) illustrates the futility of such uncontrolled studies: in uncontrolled preliminary trials of chlordiazepoxide they gained the impression that it was an excellent agent for the treatment of alcohol-withdrawal symptoms, but in a subsequent double-blind study they came to the conclusion that it was no better than saline solution. Rosenfeld and Bizzoco (1961) conducted an apparently welldesigned double-blind controlled study which indicated that chlordiazepoxide was significantly better than placebo. However, they did not describe the criteria by which the response was assessed, nor did they compare the effect of chlordiazepoxide with that of other drugs currently in use.
Such considerations are of great importance in reaching a valid conclusion about the relative merits of different drug therapies, or even the real usefulness of any of the drugs available. The findings of the present study suggest that the benefits produced by the active drugs added only slightly to the major benefits produced by the therapeutic environment. All the placebo patients were able to carry on through the three days of the study with no serious ill effects except for one case of delirium tremens. They slept moderately well at night (data not included here), and ate at least as well as the patients in the active drug groups. As noted above, the clinical staff were unable to detect any difference in their behaviour or apparent well-being in comparison with the other groups. It may well be that the placebo effect of giving any type of medication is an important part of the therapeutic environment for alcoholic patients (Bartholomew and Guile, 1961) . If 'this is so, it is all the more important to weigh carefully any additional benefit conferred by an active drug against the hazards which it may involve. The techniques employed in the present study appear to have been quite adequate for the purposes outlined. The methods employed for objective quantitative assessment of response consumed very little more of the physician's time than would have been required for ordinary clinical observation. Together with the double-blind organization of the study, they effectively prevented the introduction of personal bias into the assessment of the drug effects. This pattern of investigation should be equally useful for the future study of other types of therapy which may be introduced for the alcohol-withdrawal syndrome.
Summay
A double-blind comparative evaluation was made of placebo, chlordiazepoxide, and promazine for the treatment of withdrawal symptoms in 58 male alcoholics admitted to hospital within 24 hours of their last drink. Chlordiazepoxide was given in total daily doses of 200 and 400 mg., and promazine in doses of 400 and 800 mg. The five treatment groups were compared with respect to hours of sleep, blood-pressure, pulse rate, spontaneous and intention tremor (measured photoelectrically), electrical resistance of the skin, and calorie intake. Observa- tions were made before the start of treatment and twice daily for three days on treatment.
Both promazine and chlordiazepoxide were more effective than the placebo in promoting sleep and diminishing sweating, but tolerance developed quickly to promazine while chlordiazepoxide remained effective. Promazine reduced tremor significantly, while chlordiazepoxide did not, or even increased it. Promazine rapidly produced a marked postural hypotension and compensatory tachycardia, while chlordiazepoxide caused a more gradual onset of hypotension. Neither drug improved the appetite compared with the placebo. Grand-mal seizures or delirium tremens occurred in five patients on promazine, one on placebo, and none on chlordiazepoxide.
Chlordiazepoxide appeared to be the better drug for the treatment of alcohol-withdrawal symptoms, but the total benefit produced by it constituted a relatively small addition to the placebo effect.
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